Bioengineered skin constructs

Principles of Tissue Engineering, Third Edition

Volumn , Issue , 2007, Pages 1167-1185

  Falanga, Vincent ^a   Faria, Katie ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ORGANOGENESIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78449295708     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370615-7/50081-0     Document Type: Chapter

References (79)

1. J.A. Abraham and M. Klagsbru (1996) Modulation of wound repair by members of the fibroblast growth factor family. R.A.F. Clark (Eds) The Molecular and Cellular Biology of Wound Repair 2nd ed New York: Plenum Press 195-248
2. J. Ansel, P. Perry and J. Brown (1990) Cytokine modulation of keratinocyte cytokines. J. Investi. Dermatol. 94(suppl), 101-107
3. R. Archer and D.J. Williams (2005) Why tissue engineering needs process engineering. Nat. Biotechnol. 23 1353-1355
4. E.V. Badiavas, D. Paquette, P. Carson and V. Falanga (2002) Human chronic wounds treated with bioengineered skin: histological evidence of host graft interactions. J. Am. Acad. Dermatol. 46 524-530
5. V. Bal, A. McIndoe, G. Denton, D. Hudson, G. Lombardi, J. Lamb and R. Lechler (1990) Antigen presentation by keratinocytes induces tolerance in human T-cells. Eur. J. Immunol. 20 1893-1897
6. E. Bell, P. Ehrlich, D.J. Buttle and T. Nakatsuji (1981) Living tissue formed in vitro and accepted as skin-equivalent of full thickness. Science 221 1052-2054
7. E.A. Blomme, J.R. Werkmeister, H. Zhou, V. Kartsogiannis, C.C. Capen and T.J. Rosol (1998) Parathyroid hormone-related protein expression and secretion in a skin organotypic culture system. Endocrine 8 143-151
8. S.T. Boyce and J.F. Hansbrough (1988) Biologic attachment, growth, and differentiation of cultured human keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery 103 421-431
9. S.T. Boyce, R. Glatter and J. Kitsmiller (1995) Treatment of chronic wounds with cultured skin substitutes: a pilot study. Wounds 7 24-29
10. H. Brem, R.S. Kirsner and V. Falanga (2004) Protocol for the successful treatment of venous ulcers. Am. J. Surg. 188 1881-1888
11. B.A. Cairns, S. deSerres, K. Kilpatrick, J.A. Frelinger and A.A. Meyer (1993) Cultured keratinocyte allografts fail to induce sensitization in vivo. Surgery 114(2), 416-422
12. Cavorsi, J., Vicari, F., Wirthlin, D. J., Ennis, W., Kirsner, R. S., O'Connell, S. M., Steinberg, J., and Falanga, V. (In press). Best-practice algorithms for
13. R.A.F. Clark (1993) Basics of cutaneous wound repair. J. Dermatol. Surg. Oncol. 19 639-706
14. M.L. Cooper, J.F. Hansbrough and J.W. Polareck (1996) The effect of an arginine-glycine-aspartic acid peptide and hyaluronate synthetic matrix on epithelialization of meshed skin graft interstices. J. Burn Care Rehabil. 17 108-116
15. G. DeImus, M. Tsoukas, C. Golomb, C. Wilkel, M. Nowak and V. Falanga (2001) Accelerated healing of pyoderma gangrenosum treated with bioengineered skin (Graftskin) and concomitant immunosuppression. J. Am. Acad. Dermatol. 44 61-66
16. A. Desmouliere and G. Gabbiani (1996) The role of the myofibroblast in wound healing and fibrocontractive diseases. R.A.F. Clark (Eds) The Molecular and Cellular Biology of Wound Repair 2nd ed. New York: Plenum Press 321-323
17. H.J.C. deVries, J.R. Mekkes, E. Middelkoop, W.L.J. Hinrichs, C.H.R. Wildevuur and W. Westerhof (1993) Dermal substitutes for full-thickness wounds in a one-stage grafting model. Wound Rep. Regen. 1 244-252
18. A.F. Falabella, L.A. Schachner, I.C. Valencia and W.H. Eaglstein (1999) The use of tissue-engineered skin (Apligraf) to treat a newborn with epidermolysis bullosa. Arch. Dermatol. 135 1219-1222
19. A.F. Falabella, I.C. Valencia, W.H. Eaglstein and L.A. Schachner (2000) Tissue-engineered sking (Apligraf) in the healing of patients wth epidermolysis bullosa wounds. Arch. Dermatol. 136 1225-1230
20. V. Falanga (1993) Chronic wounds: pathophysiological and experimental considerations. J. Invest. Dermatol. 100 751-755
21. V. Falanga (2001) Classifications for wound preparation and stimulation of chronic wounds. Wound Rep. Regen. 8 347-352
22. V. Falanga (2005) Wound healing and its impairment in the diabetic foot. Lancet 366 1736-1743
23. V. Falanga and W.H. Eaglstein (1993) The trap hypothesis of venous ulceration. Lancet 341 1006-1008
24. V. Falanga and M. Sabolinski (1999) A bilayered living skin construct (Apligraf) accelerates complete closure of hard-to-heal venous ulcers. Wound Rep. Reg. 7 201-207
25. V. Falanga and M.L. Sabolinski (2000) Prognostic factors for healing of venous and diabetic ulcers. Wounds 12 42A-46A
26. V. Falanga, D. Margolis, O. Alvarez, M. Auletta, F. Maggiacomo, M. Altman, J. Jensen, M. Sabolinski and J. Hardin-Young (1998) Human Skin Equivalent Investigators Group. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch. Dermatol. 134 293-300
27. V. Falanga, C. Isaacs, D. Paquette, G. Downing, N. Kouttab, J. Butmarc, E. Badiavas and J. Hardin-Young (2003) Wounding of bioengineered skin: cellular and molecular aspects after injury. J. Invest. Dermatol. 119 653-660
28. C.E. Fife, C. Buyukcakir, G.H. Otto, et al. (2002) The predictive value of transcutaneous oxygen tension measurement in diabetic lowerextremity ulcers treated with hyperbaric oxygen therapy: a retrospective st. Wound Rep. Regen. 10 198-207
29. D.P. Fivenson and A.F. Falabella (2000) The use of Graftskin (Apligraft) for the treatment of epidermolysis bullosa. Wounds 12 64A-71A
30. D.P. Fivenson, L. Schershun, M.D. Choucair, D. KuKuruga, J. Young and T. Shwayder (2003) Graftskin therapy in epidermolysis bullosa. J. Am. Acad. Dermatol. 48 886-892
31. D.P. Fivenson, L. Scherschun and L.V. Cohen (2003) Apligraf in the treatment of severe mitten deformity associated with recessive dystophic epidermolysis bullosa. Plast. Reconstruc. Surg. 112 584-588
32. G.C. Gallico III, N.E. O'Connor, C.C. Compton, O. Kehinde and H. Green (1984) Permanent coverage of large burn wounds with autologous cultured human epithelium. N. Eng. J. Med. 311 448-451
33. A.A. Gaspari and S.I. Katz (1988) Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J. Immunol. 140 2956-2963
34. A.A. Gaspari and S.I. Katz (1991) Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia + keratinocytes. J. Immunol. 147(12), 4155-4161
35. H. Green, O. Kehinde and J. Thomas (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc. Nat. Acad. Sci. U.S.A. 76 5665-5668
36. D. Greiling and R.A. Clark (1997) Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J. Cell Sci. 110 861-870. Pt. 7
37. M. Griffiths, N. Ojeh, R. Livingstone, R. Price and H. Navsaria (2004) Survival of Apligraf in acute human wounds. Tissue Eng. 10 1180-1195
38. J.F. Hansbrough, S.T. Boyce, M.L. Cooper and T.J. Foreman (1989) Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. J. Am. Med. Assoc. 262 2125-2130
39. J.M. Hefton, M.R. Madden, J.L. Finkelstein and G.T. Shires (1983) Grafting of burn patients with allografts of cultured epidermal cells. Lancet 2(8347), 428-430
40. D. Heimbach, A. Luterman, J.F. Burke, A. Cram, D. Herndon, J. Hunt, M. Jordan, W. McManus, L. Solem and N.G. Ward (1988) Artificial dermis for major burns: a multicenter randomized clinical trial. Ann. Surg. 208 313-320
41. B-C. Kim, H.T. Kim, S.H. Park, J-S. Cha, T. Yufit, S-J. Kim and V. Falanga (2003) Fibroblasts from chronic wounds show altered TGF-β type II receptor expression. J. Cell. Physiol. 195 331-336
42. R.C. Langdon, C.B. Cuono, N. Birchall, J.A. Madri, E. Kuklinska, J. McGuire and G.E. Moellmann (1988) Reconstitution of structure and cell function in human skin grafts derived from cryopreserved allogeneic dermis and autologous cultured keratinocytes. J. Invest. Dermatol. 91 478-485
43. M.B. Lappin, I. Kimnber and M. Norval (1996) The role of dendritic cells in cutaneous immunity. Arch. Dermatol. Res. 288 109-121
44. V. Lattari, L.M. Jones, J.R. Varcelotti, B.A. Latenser, H.F. Sherman and R.R. Barrette (1997) The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J. Burn Care Rehabil. 18 147-155
45. M.J. Lysaght and A.L. Hazlehurst (2004) Tissue engineering: the end of the beginning. Tissue Eng. 10 309-320
46. J. Mansbridge, K. Liu, R. Patch, K. Symons and E. Pinney (1998) Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range. Tissue Eng. 4 403-414
47. W.A. Marston, J. Hanft, P. Norwood and R. Pollak (2003) The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26 1701-1705
48. I.A. McKay and I.M. Leigh (1991) Epidermal cytokines and their roles in cutaneous wound healing. Br. J. Dermatol. 124 513-518
49. E. Middelkoop, H.J.C. deVries, L. Ruuls, V. Everts, C.H.R. Wildevuur and W. Westerhof (1995) Adherence, proliferation, and collagen turnover by human fibroblasts seeded into different types of collagen sponges. Cell Tissue Res. 280 447-453
50. K.S. Moulon, R.J. Melder, V. Dharmidharka, J. Hardin-Young, R.K. Jain and D.M. Briscoe (1999) Angiogenesis in the huPBL-SCID model of human transplantation rejection. Tranplantion. 67 1626-1631
51. W.K. Nahm, B.D. Philpot, M.M. Adams, E.V. Badiavas, L.H. Zhou, J. Butmarc and V. Falanga (2004) Significance of N-methyl-daspartate (NMDA) receptor-mediated signaling in human keratinocytes. J. Cell. Physiol. 190 309-317
52. B.J. Nickoloff and L.A. Turka (1994) Immunological functions of nonprofessional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol. Today 15(10), 464-469
53. B.J. Nickoloff, et al. (1986) Human keratinocyte-lymphocyte reactions. in vitro. J. Invest. Dermatol. 87(1), 11-18
54. B.J. Nickoloff, R.S. Mitra, K. Lee, L.A. Turka, J. Green, C. Thompson and Y. Shimizu (1993) Discordant expression of CD29 ligands, BB-1 and B7 on keratinocytes in vitro and psoriatic cells. in vivo. Am. J. Pathol. 142(4), 1029-1040
55. D. Niederwieser, J. Aubock, J. Troppmair, M. Herold, G. Schuler, G. Boeck, J. Lotz, P. Fritsch and C. Huber (1988) IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. J. Immunol. 140(8), 2556-2564
56. C.J. Nolte, M.A. Oleson, J.F. Hansbrough, J. Morgan, G. Greenleaf and L. Wilkins (1994) Ultrastructural features of composite skin cultures grafted onto athymic mice. J. Anat. 185 325-333
57. R. Odessey (1992) Addendum: multicenter experience with cultured epidermal autograft for the treatment of burns. J. Burn Care Rehab. 13 174-180
58. L.G. Ovington (2001) Wound care products: how to choose. Adv Wound Manage. 40 259-264
59. N.L. Parenteau, M. Sabolinski, S. Prosky, C. Nolte, M. Oleson, K. Kriwet and P. Bilbo (1996) Biological and physical factors influencing the successful engraftment of a cultured human skin substitute. Biotechnol. Bioeng. 52 3-14
60. N.L. Parenteau, M.L. Sabolinski, G. Mulder and D.T. Rovee (1997) Wound research. D. Krasner, D. Kane (Eds) Chronic Wound Care: A Clinical Source for Healthcare Professionals” 2nd ed Wayne, PA: Health Management Publications 389-395
61. T.J. Phillips, O. Kehinde, H. Green and B.A. Gilchrest (1989) Treatment of skin ulcers with cultured epidermal allografts. J. Am. Acad. Dermatol. 21 191-199
62. T.J. Phillips, J. Manzoor, A. Rojas, C. Isaacs, P. Carson, M. Sabolinski, J. Young and V. Falanga (2002) The longevity of a bilayered skin substitute after application to venous ulcers. Arch. Dermatol. 138 1079-1081
63. R.P. Phipps, R.L. Roper and S.H. Stein (1989) Alternative antigen presentation pathways: accessory cells which down-regulate immune responses. Regional Immunol. 2 326-339
64. J.S. Pober, T. Collins, J.M.A. Bimmbrone Jr.M.A., P. Libby and C.S. Reiss (1986) Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 41(2), 141-146
65. J.G. Rheinwald and H. Green (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6 331-344
66. M.C. Robson, B.D. Stenberg and J.P. Heggers (1990) Wound-healing alterations caused by infection. Clin. Plast. Surg. 17 485-492
67. L. Saap, K. Donohue and V. Falanga (2004) Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers. Dermatol. Surg. 30 1095-1100
68. M.L. Sabolinski, O. Alvarez, M. Auletta, G. Mulder and N.L. Parenteau (1996) Cultured skin as a “smart material” for healing wounds: experience in venous ulcers. Biomaterials 17 311-320
69. D.L. Steed, J.J. Ricotta, J.J. Prendergast, R.J. Kaplan, M.W. Webster, J.B. McGill and S.L. Schwartz (1995) Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group. Diabetes Care 39-46
70. J.T. Shen and V. Falanga (2000) Treatment of venous ulcers using a bilayered living skin construct. Surg. Technol. Int. IX 77-80
71. M.B. Siroky (2002) Pathogenesis of bacteriuria and infection in the spinal cord-injured patient. Am. J. Med. 113 67S-79S
72. J.W. Streilien and P.R. Bergstresser (1984) Langerhans cells: antigen-presenting cells of the epidermis. Immunobiology 168 285-300
73. J. Thivolet, M. Faure, A. Demide and G. Mauduit (1986) Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation 42(3), 274-280
74. A. Veves, V. Falanga, D.G. Armstrong and M.L. Sabolinski (2001) Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized trial. Diabetes Care 24 290-295
75. L.M. Wilkins, S.R. Watson, S.J. Prosky, S.F. Meunier and N.L. Parenteau (1994) Development of a bilayered living skin construct for clinical applications. Biotechnol. Bioeng. 43 747-756
76. I.R. Williams and T.S. Kupper (1996) Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci. 58(18), 1485-1507
77. G. Winter (1962) Formation of scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 193 293-294
78. I.V. Yannas, J.F. Burke, D.P. Orgill and E.M. Skrabut (1982) Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 215 174-176
79. I.V. Yannas, E. Lee, D.P. Orgill, E.M. Skrabut and G.F. Murphy (1989) Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc. Nat. Acad. Sci. U.S.A. 86